WOC Pharma & Healthcare Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

WOC Pharma & Healthcare Growth Direct Plan

NAV
₹10.1330
-0.62%
(24 May)
AUM
113 Cr
TER
0.61%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+110.2%
+110.0%
+104.2%
+88.5%
NA
3Y
+41.8%
+42.6%
+43.7%
+40.2%
NA
5Y
+26.5%
+31.8%
NA
+28.7%
NA
ALL
+13.6%
+19.4%
+35.5%
+17.5%
+1.3%
VOL
19.9%
19.0%
21.8%
19.0%
11.7%
TER
0.9%
0.9%
0.5%
1.2%
0.6%
AUM
₹2,352 Cr
₹957 Cr
₹4,115 Cr
₹5,043 Cr
₹113 Cr
INFO
0.68
1.02
1.63
0.92
0.11
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
WOC Pharma & Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
Sun Pharmaceuticals Industries Ltd
11.4%
Cipla Ltd
9.1%
Torrent Pharmaceuticals Ltd
5.8%
Zydus Lifesciences Ltd
5.3%
Mankind Pharma Ltd
4.2%
Max Healthcare Institute Ltd Ordinary Shares
3.8%
Abbott India Ltd
3.4%
J.B. Chemicals & Pharmaceuticals Ltd
3.3%
Krishna Institute of Medical Sciences Ltd
3.1%
Ajanta Pharma Ltd
3.0%
Top industry exposure
Healthcare
90.7%
Basic Materials
3.0%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 30 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Piyush Baranwal
Ramesh Mantri
Dheeresh Pathak
Naitik Shah

FAQs